Carnahan, MD, ABIHM, IFMCP Dr
IBX will no longer cover drugs like Ozempic when they are prescribed solely for weight loss GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that affect all members, whether they utilize weight loss drugs or not, IBX said in a statement
In our latest Diabetech podcast, I spoke with longtime diabetes advocate and healthcare executive Marie Schiller about the real-world use of GLP-1s in T1D, the latest research findings, and possible pathways to coverage
How GLP-1 Medications Interact With These Pathways Compounded semaglutide and similar GLP-1 receptor agonists address several of these fatigue contributors simultaneously, which is part of why patients often report energy improvements that feel disproportionate to the amount of weight lost
While many people tolerate semaglutide well, some might experience adverse reactions
Effects of Liraglutide on Weight, Satiation, and Gastric Functions in Obesity: A Randomised, Placebo-Controlled Pilot Trial